Related Experiment Video
Updated: May 29, 2026
Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
[Critical limb ischemia--update]
Eitan Melamed1, Baydousi Kotyba, Offer Galili
1Department of Vascular Surgery, Carmel Medical Center, Haifa, Israel. Eitanme2000@yahoo.com
Insights
Critical limb ischemia (CLI), a severe peripheral artery disease, requires timely revascularization to prevent limb loss. Treatment options like endovascular therapy or surgery depend on patient factors for optimal outcomes.
Area of Science:
- Vascular Surgery
- Cardiovascular Medicine
- Peripheral Artery Disease
Context:
- Critical limb ischemia (CLI) represents the most severe stage of peripheral artery occlusive disease.
- CLI poses significant risks of limb loss and mortality without prompt diagnosis and intervention.
- Current therapeutic goals focus on risk factor reduction, pain relief, ulcer healing, amputation prevention, and survival enhancement.
Purpose:
- To outline the therapeutic goals and management strategies for patients with critical limb ischemia.
- To compare the efficacy and patient selection criteria for endovascular therapy versus surgical bypass.
- To guide clinical decision-making in the treatment of CLI.
Summary:
- Treatment options for CLI include medical management, endovascular revascularization, surgical bypass, and amputation.
- Endovascular therapies have advanced, offering solutions for long-segment occlusive disease.
- Surgical bypass may offer more durable results, particularly for younger, active patients or in cases of endovascular failure.
- Endovascular therapy may be preferable for frail patients with limited life expectancy.
- Amputation is considered for non-ambulatory patients or those unfit for revascularization.
Impact:
- Optimizing treatment selection can improve patient quality of life and survival rates.
- Advances in endovascular techniques expand treatment possibilities for CLI.
- Understanding patient-specific factors is crucial for achieving better outcomes in CLI management.
Abstract:
Critical limb ischemia (CLI) is the most severe manifestation of peripheral artery occlusive disease. Without timely diagnosis and revascularization, patients with CLI are at risk of devastating complications including loss of limb and life. Therapeutic goals in treating patients with CLI include reducing cardiovascular risk factors, relieving ischemic pain, heating ulcers, preventing major amputation, improving quality of life and increasing survival. These aims may be achieved through medical therapy, revascularization or amputation. The past decade has seen substantial growth in endovascular therapies and options now exist for treating long segment occlusive disease, but surgical bypass may still yield more durable results. Patients who are younger, more active, and at low risk for surgery, may have better outcomes undergoing an operation. This is also indicated for endovascular failures, which may include technical failures or late occlusions after stents or other procedures. In contrast, frail patients with a limited life expectancy may experience better outcomes with endovascular therapy. For patients who are non-ambulatory, demented, or unfit to undergo revascularization, an amputation should be considered.
Related Concept Videos
01:27Peripheral Artery Disease III: Interprofessional Care
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
01:23Peripheral Artery Disease V: Postoperative Nursing Management
01:17Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
01:26Peripheral Artery Disease IV: Nursing Management
01:15Ischemic Stroke ll: Pathophysiology